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Abstract 
 
Alcoholism is a widespread problem, and although we are beginning to characterize genes that 
mediate its heritable nature, we still do not understand how a family history of alcoholism places 
individuals at risk for this disorder.  One trait that is consistently elevated, both in alcoholics and 
those who suffer from a variety of addictive disorders, is impulsivity.  Impulsivity can be defined 
as a self-defeating tendency to choose immediate, but small rewards over large rewards given at 
following a delay.  Normally, instituting a delay to a reward decreases its subjective value, a 
phenomenon called delay discounting.  In alcoholics, the slope of this decline in value as a 
function of time is steeper than in non-drinkers, but it has been difficult to demonstrate in 
humans whether this results from a lifetime of drinking, or causes problem drinking in the first 
place.  In the present studies we utilized an animal model of alcoholism, the selectively bred 
High Alcohol Preferring (HAP) mouse, comparing them to Low Alcohol Preferring (LAP) mice 
as well as non-selected, outbred mice using the translational measure of impulsivity, delay 
discounting.  By using alcohol naïve mice, we were able to assess whether genes promoting 
alcohol drinking increase impulsivity without the potential confound of a history of alcohol 
exposure.  In follow-up studies, we assessed whether pharmacotherapies for alcoholism decrease 
impulsivity as well as alcohol consumption in HAP mice.  Alcohol naïve HAP, LAP, and HS/Ibg 
mice were subjected to a saccharin-motivated delay discounting procedure in which the value of 
an immediate reward was titrated until it was subjectively equivalent to a delayed reward.  As 
expected, time to the delayed reward decreased its value, and did so more steeply in HAP mice 
than in LAP and unselected HS/Ibg mice, supporting the hypothesis that impulsivity plays a 
causal role in initiating high drinking behavior.  In related studies, we assessed whether two 
pharmacotherapies for alcoholism, memantine (an NMDA antagonist) and naltrexone (an opioid 
antagonist), altered delay discounting behavior and (in separate mice) alcohol drinking.  
Although these two drugs decreased free-choice drinking in HAP mice, consistent with their 
beneficial effects on alcoholism, they did not alter impulsivity.  Amphetamine, a general 
dopamine agonist with known anti-impulsive actions, decreased impulsivity in HAP mice, but 
did not alter alcohol consumption in a behaviorally selective manner.  These findings support a 
role for impulsivity in the development of alcoholism, but leave unanswered the question of 
which neural systems would serve as the best pharmacological targets for the development of 
medications aimed at treating those with, or at a high risk for, alcoholism.   
 
 
